IspecimenISPC
13F holders, Q4 2024 (December 31)7holders +1
2new positions
2sold out
$2.65avg. 13F price*
At the end of Q4 2024, 7 institutions reported holding Ispecimen Inc. (ISPC) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 2 sold out. The largest holders were Bridgeway Capital Management, LLC ($58K), UBS Group AG ($29K) and BlackRock, Inc. ($8K).
- Company
- Ispecimen Inc.
- CUSIP
- 45032V207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $58K |
| Exits | 2 | $157K |
All 13F filers, Q3 2024 → Q4 2024: 31,307 shares bought and 34,484 shares sold, net −3,177 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Bridgeway Capital Management, LLC | 0.00% | New | 21,800 | $58K |
| UBS Group AG | 0.00% | Add +647.0% | 10,974 | $29K |
| BlackRock, Inc. | 0.00% | No change | 2,827 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -88.8% | 131 | $348 |
| Bank of America Corp. | 0.00% | Reduce -88.1% | 7 | $19 |
| Sachetta, LLC | 0.00% | New | 2 | $6 |
| SBI Securities Co., Ltd. | 0.00% | — | 2 | $5 |
"% of holder's portfolio" is ISPC's weight in each manager's 13F, not the share of Ispecimen Inc. the manager owns.